MODI PRIX GALIEN INDIA
The life science industry’s preeminent accolade for research and innovation to benefit the human condition was celebrated in India for the first time!
The First edition of the Modi Prix Galien India Awards presented by the Gujar Mal Modi Science Foundation and its President Satish Kumar Modi, took place March third at the Taj Mahal Hotel - New Delhi.
See the Highlights from the Forum and the Ceremony
India is a key player in the production of medicines both in sheer volume and in value worldwide and is the global leader in the production of generic drugs and vaccines ensuring accessibility to treatment to the underprivileged.
India represents the largest population of academics in the fields of science and technology per capita. Many exciting treatments and technologies are being developed in India today with tremendous potential to treat and cure disease on a global scale. The Galien Foundation is proud to recognize the teams working tirelessly to ensure positive change to human health.
India’s Minister of Health and Family Welfare bestows first Modi Prix Galien Prizes
The transformation of India's healthcare landscape can be attributed to the government’s strategic focus and keen emphasis on the burgeoning sector, writes Former DBT Secretary Dr. Manju Sharma. Read about it in CNBC.
Best Startup / Digital Health Solution
Best Medical Technology
Best Product for Rare / Orphan Diseases
Best Biotechnology Product
Best Academic / Public Sector
Submission is a simple, easy process. A quick fact sheet and explanatory video of the submission process is available on demand.
As early as the sixth century BC, Sushruta, recognized as the “father of surgery” in ancient India, introduced pioneering operations and healing techniques.
He authored Sushruta-samhita, the first important treatise on surgery in the country providing a crucial source of information on matters of surgery, toxicology, pharmacology and pediatrics.
With its long and rich history, the India of today has the academic and scientific infrastructure, the R&D and technology transfer frameworks, the entrepreneurship and the funding to predict double digit growth rates in our current decade. It is no wonder that the world is looking at India with anticipation for new breakthroughs in health.
Prix Galien salutes the nation that has forged a formidable growth strategy in the life science sector since 1970, the year Prix Galien was founded, to become the “World’s Pharmacy” as it is often referred to today. India’s thriving life science sector represents the highest number of FDA approved production facilities outside the US and the country only continues to grow.
The Prix Galien India will be fundamental in:
- Recognizing and promoting excellence and through recognition, while enhancing and encouraging a cycle of scientific research excellence and innovation.
- Fostering a culture of innovation which values creative thinking, risk taking and the development of solutions that address societal challenges and contribute to economic growth.
- Showcasing India’s scientific excellence and potential on the international stage.
We look forward to inducting India’s distinguished innovators to the Galien Foundation Hall of Fame in 2024. The winners will join an illustrious list of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.
The Prix Galien India Awards committee include 12 esteemed leaders in the life sciences in India. The committee is a neutral body and follows the Prix Galien India Charter (that will be released soon) in selecting the best of the best in biopharmaceutical research and development. The selection committee will be supported by two subcomittees that will short list finalists to the competition.
COMMITTEE CHAIR:
Professor Manju Sharma, Former Secretary to the Govt. of India, Department of Biotechnology. Chair New Initiative, NASI, Allahabad
JURY MEMBERS:
Dr Alok Dhawan, Centre for Biomedical Research. Lucknow
Shri Anil Khanna, Sr. Vice President, GM Modi Science Foundation, New Delhi
Prof Paramjit Khurana, Member Secretary
Prof Indranil Manna, Vice Chancellor of BIT Mesra, Ranchi
Prof Ashwani Nangia, Dept. Of Chemistry, University of Hyderabad
Prof Narinder Kr. Mehra, Honorary Emeritus scientist of Indian council of Medical Research & Former Dean and National chair of All India Institute of Medical Sciences
Dr Himanshu Pathak, Secretary, Department of Agricultural Research and Education (DARE) & Director General, Indian Council of Agricultural Research (ICAR)
Dr Ram Gopal Rao, Vice Chancellor, BITS Pilani
Dr Shiv Kumar Sarin, President, National Academy of Medical Sciences
Prof Anurag Sharma, IIT Delhi – Member Secretary
Dr Sanjay Singh, Chief Executive Officer . Gennova Biopharmaceuticals Ltd.
Dr Rohit Srivastava, IIT-Mumbai
Dr Renu Swarup, Former Secretary, DBT, New Delhi
Prof Umesh Waghmare, Professor in the Theoretical Sciences Unit of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)
Sub-committee in the categories Best Biotechnology Product and Best Product for Orphan/Rare Disease
Prof Sudha Bhattacharya, INSA Sr. Scientist, Ashoka University
Prof Alok Dhawan, Director, Centre of BioMedical Research, Lucknow
Prof Paramjit Khurana, South Campus, University of Delhi – Convenor
Prof Radha Rangrajan, Director, CDRI-CSIR, Lucknow
Prof Shashibala Singh, Director, NIPER, Hyderabad
Prof Nikhil Tandon, AIIMS, New Delhi
Prof Sudhanshu Vrati, Regional Centre for Biotechnology, Faridabad
Sub-committee in the categories Best Medical Technology (including diagnostics tools), Best StartUp & Digital Health
Prof Madhu Dixit, CDRI, Lucknow
Dr K.R. Suresh Nair, Chief Technology Advisor to Foundation for Innovation and Social Entrepreneurship, an initiative of Tata Trust
Dr V. Premnath, Chief Scientist, Polymer Science & Engineering, NCL. Pune
Prof Vijayalakshmi Ravindranath, Centre for Neuroscience, Indian Institute of Science, Bangalore
Dr Jitendra Sharma, AMTZ Campus, Visakhapatnam
Dr Rohit Srivastava, IIT, Mumbai – Convenor
Dr Mrutyunjay Suar, DG R&D and Innovation at KIIT University, Bhubaneswar
“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, President of the United States – 2008
“The launch of Prix Galien India is a meaningful tribute to India’s contributions to scienceand medicine, and to the ways India’s talent and ingenuity strengthen our shared work of forging a healthier future for all.”
- Vas Narasimhan, CEO of Novartis
“The Prix Galien USA recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe.”